Contracts Finder · Award
NHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1
A public procurement published by NHS England via Contracts Finder.
- £11m
- Award value
- £5.5m
- Tender value
- 3
- Suppliers
- 6
- Awards
- 2
- Notices
- Award
- Stage
Overview
NHS England has created a Framework Agreement with 5 providers who are able to provide between them up to 10,500 behavioural interventions annually across the 42 Integrated Care Systems (ICS) in England. The Framework providers are; Counterweight, Xyla, Reed Wellbeing, Oviva and Momenta Newcastle. The Framework Agreement will include an option for it to be extended for a further 12 months in addition to the initial 2 year term upon review. During the term of the Framework and any extension period, NHS England reserves the right, should funding become available, to increase the number of behavioural interventions. Wave 1 was for 10 ICSs with the following Framework suppliers being suc…
Key details
- Buyer
- NHS England
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 85100000 — Health services
- Currency
- GBP
- Total award value
- £10,962,786
- Tender value
- £5,481,393
- First published
- 20 Feb 2024
- Last updated
- 20 Feb 2024
Awards
6 awards recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Pulse Healthcare Limited | 03156103 | 6 Aug 2023 | active | £5.5m |
| Oviva UK Limited | 09667784 | 6 Aug 2023 | active | £5.5m |
| Momenta Newcastle Ltd | 12371057 | 6 Aug 2023 | active | £5.5m |
| Pulse Healthcare Limited | 03156103 | 6 Aug 2023 | active | £5.5m |
| Oviva UK Limited | 09667784 | 6 Aug 2023 | active | £5.5m |
| Momenta Newcastle Ltd | 12371057 | 6 Aug 2023 | active | £5.5m |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from NHS England
FAQs about this procurement
Who is the buyer for "NHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1"?
NHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1 is a UK public-sector procurement published by NHS England via Contracts Finder.
Has "NHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1" been awarded?
Yes — 6 awards are recorded, with a reported total value of £10,962,786. The current lifecycle stage is "Award".
Which suppliers are involved in "NHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1"?
3 suppliers are linked: Pulse Healthcare Limited, Oviva UK Limited, Momenta Newcastle Ltd.
What is "NHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1" worth?
The reported award value is £10,962,786.
When was "NHS Type 2 Diabetes Path to Remission Programme (previously LCD) Wave 1" published?
It was first published on 20 Feb 2024 and last updated on 20 Feb 2024, across 2 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable